Regulators will be able to review data in real time under a rolling review process, which is created to help speed up the approval timeline of potential vaccines for the novel coronavirus, which causes COVID-19.
A vaccine that hasn't gained enough public trust will therefore have a limited ability to control the pandemic even if it's highly effective.
The prestigious scientific journal said the findings were "encouraging" because older individuals are at disproportionate risk of severe COVID-19. That level of trust takes time to rebuild if it has been eroded.
The Union Minister said, "I am confident that the COVID-19 vaccine will be ready in the next three-four months". Specialist advice should be sought about your specific circumstances.
"We were pleased to see that our vaccine was not only well tolerated in older adults, but also stimulated similar immune responses to those seen in younger volunteers".
Early results from this crucial stage are expected in the coming weeks.
The Oxford-AstraZeneca coronavirus vaccine is showing a strong immune response in adults whose age are in the 60s and 70s.
The minister said one can protect oneself from this deadly virus with small precautions like wearing a good quality mask properly, maintaining social distance and taking care of hand-hygiene.
Apple to pay $113m to settle iPhone 'batterygate'
This new investigation was launched by more than 30 states, including Arizona, Arkansas, and IN , according to a press release. Instead, the states said Apple benefited from customers - exhausted of slower, aging phones - purchasing new model iPhones.
"The government has signed agreements with seven vaccine developers to secure the most promising vaccines for the UK".
Immune responses from vaccines tend to lessen as people get older as the immune system gradually slows with age.
"We want to purchase at least 10 million doses of Chinese vaccine in December, the contract will be signed within one-two days".
"We set ourselves the task of ensuring the immunization of as many people as possible with tested, high-quality and safe vaccines in 2021, both through global initiatives and funds from the state budget of Ukraine", Liashko stressed.
The manufacturers said the vaccine was undergoing larger, more comprehensive phase 3 trials to confirm the results.
Combined phase-2 and phase-3 clinical trials of the Russian Covid-19 vaccine, Sputnik V, will be conducted soon in India by pharma major Dr Reddy's Laboratories.